Literature DB >> 7856826

A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunosorbent assay.

W Roeffen1, T Lensen, B Mulder, K Teelen, R Sauerwein, J Van Druten, W Eling, J H Meuwissen, P J Beckers.   

Abstract

Monoclonal antibodies (MAbs) 32F1 and 32F3 react with two independent epitopes of a protein doublet with molecular weights of 48 and 45 kilodaltons (kD) expressed on the surface of Plasmodium falciparum (Pfs48/45) macrogametes and zygotes; only 32F3 blocks transmission. These MAbs were used to develop a Pfs48/45-specific competition enzyme-linked immunosorbent assay (ELISA) using 32F1 to capture antigen and labeled 32F3 for quantification and analysis of the contribution of antibodies in human serum to transmission-blocking activity. A comparison analysis was used to determine agreement of competition ELISA titers and transmission-blocking activity as observed in the bioassay in three groups of serum samples: 37 from European travelers with previous exposure to malaria, 56 from gametocyte carriers, and 66 from schoolchildren from a malaria-endemic area in Cameroon. The index of agreement between outcomes of the ELISA and transmission-blocking assay in gametocyte carriers and in travelers was specifically defined as fair-to-moderate; in schoolchildren the agreement was not significant. The combined analysis of all sera showed a significant and fair-to-moderate agreement between the results of the competition ELISA and the transmission-blocking assay, with a relative specificity of 94% (of 105 cases negative in the transmission-blocking assay, 99 were also negative in the competition ELISA) and a relative sensitivity of 44% (of 54 cases positive in the transmission-blocking assay, 24 were also positive in the competition ELISA). This study shows that a positive C48/45-ELISA is indicative for transmission-blocking activity in the mosquito assay, while a negative result does not exclude transmission-blocking activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856826     DOI: 10.4269/ajtmh.1995.52.60

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Sequence polymorphisms in Pvs48/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea.

Authors:  Mi Kyung Woo; Kyeong Ah Kim; JuYeon Kim; Jun Seo Oh; Eun Taek Han; Seong Soo A An; Chae Seung Lim
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

2.  Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.

Authors:  J Healer; D McGuinness; P Hopcroft; S Haley; R Carter; E Riley
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.

Authors:  Teun Bousema; Will Roeffen; Hinta Meijerink; Harry Mwerinde; Steve Mwakalinga; Geert-Jan van Gemert; Marga van de Vegte-Bolmer; Frank Mosha; Geoffrey Targett; Eleanor M Riley; Robert Sauerwein; Chris Drakeley
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

4.  Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice.

Authors:  Nikolay S Outchkourov; Will Roeffen; Anita Kaan; Josephine Jansen; Adrian Luty; Danielle Schuiffel; Geert Jan van Gemert; Marga van de Vegte-Bolmer; Robert W Sauerwein; Hendrik G Stunnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

5.  Plasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana.

Authors:  Ruth Ayanful-Torgby; Akua Oppong; Joana Abankwa; Festus Acquah; Kimberly C Williamson; Linda Eva Amoah
Journal:  Malar J       Date:  2016-12-09       Impact factor: 2.979

6.  A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.

Authors:  Debabani Roy Chowdhury; Evelina Angov; Thomas Kariuki; Nirbhay Kumar
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

Review 7.  Recent advances in recombinant protein-based malaria vaccines.

Authors:  Simon J Draper; Evelina Angov; Toshihiro Horii; Louis H Miller; Prakash Srinivasan; Michael Theisen; Sumi Biswas
Journal:  Vaccine       Date:  2015-10-11       Impact factor: 3.641

8.  Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.

Authors:  Li Zheng; Wei Pang; Zanmei Qi; Enjie Luo; Liwang Cui; Yaming Cao
Journal:  Parasit Vectors       Date:  2016-08-08       Impact factor: 3.876

9.  Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

Authors:  Prasun Kundu; Anthony Semesi; Matthijs M Jore; Merribeth J Morin; Virginia L Price; Alice Liang; Jingxing Li; Kazutoyo Miura; Robert W Sauerwein; C Richter King; Jean-Philippe Julien
Journal:  Nat Commun       Date:  2018-10-26       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.